Thermo Fisher ScientificBSP:TMOS34 +7.04%74 Interest Coverage is 5.40 as of Mar. 2026, which is 6% below its 10-year median of 5.74. GuruFocus rates BSP:TMOS34 with a GF Score™ of 74/100 and a GF Value™ of R$63.08 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 95 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks worse than 65.26% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Thermo Fisher Scientific's
Operating Income
for the
three
months ended in Mar. 2026 was R$10,004 Mil. Thermo Fisher Scientific's Interest Expense for the
three
months ended in Mar. 2026 was R$-1,851 Mil.
Thermo Fisher Scientific's interest coverage for the quarter that ended in Mar. 2026 was 5.40.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Thermo Fisher Scientific's Interest Coverage or its related term are showing as below:
BSP:TMOS34'
s Interest Coverage Range Over the Past 10 Years
Min: 5.16 Med: 5.74 Max: 19.08
Current: 5.58
BSP:TMOS34's Interest Coverage is ranked worse than 65.26% of 95
companies
in the Medical Diagnostics & Research industry
Industry Median: 9.05
vs BSP:TMOS34: 5.58
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Thermo Fisher Scientific Interest Coverage Related Terms
Thermo Fisher Scientific Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BSP:TMOS34 vs DHR, IDXX, A: Interest Coverage Comparison
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (BSP:TMOS34) has a Interest Coverage of 5.40 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Thermo Fisher Scientific and its competitors. This is near median its historical median of 5.74. Over the past decade, Thermo Fisher Scientific's Interest Coverage has ranged from 5.16 to 19.08. According to the industry distribution chart, Thermo Fisher Scientific ranks #62 out of 95 companies in the Medical Diagnostics & Research industry, placing it in the top 65.3%.
Is Thermo Fisher Scientific's Interest Coverage too high?
Thermo Fisher Scientific's current Interest Coverage of 5.40 is near median its 10-year median of 5.74. Over the past 10 years, this metric has ranged from a low of 5.16 to a high of 19.08. The Medical Diagnostics & Research industry median Interest Coverage is 9.05. Thermo Fisher Scientific's value of 5.40 is 40.3% below this industry median. Based on the distribution chart, Thermo Fisher Scientific ranks #62 out of 95 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Thermo Fisher Scientific has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Interest Coverage compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #62 out of 95 companies for Interest Coverage. This places Thermo Fisher Scientific in the lower half of its industry. The industry median Interest Coverage is 9.05. Thermo Fisher Scientific's value of 5.40 is 40.3% below this benchmark. Historically, Thermo Fisher Scientific's own Interest Coverage has ranged from 5.16 to 19.08 over the past decade. While the company's 10-year median is 5.74 vs. the industry median of 9.05, Thermo Fisher Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.05, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thermo Fisher Scientific's current Interest Coverage of 5.40 is 40.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Thermo Fisher Scientific and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thermo Fisher Scientific's current Interest Coverage is 5.40, which is near median its own 10-year median of 5.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$63.08, compared to a current price of R$53.25 — trading 15.6% below its estimated fair value. The current Interest Coverage is 5.40, which is near median its 10-year median of 5.74 and 40.3% below the Medical Diagnostics & Research industry median of 9.05. Thermo Fisher Scientific's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current Interest Coverage is 5.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?
Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued.
The current stock price of R$53.25 is trading 15.6% below its estimated GF Value™ of R$63.08.
GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.
Key valuation signals for BSP:TMOS34:
Interest Coverage: 5.40 (near median its 10-year median of 5.74)
GF Value™: R$63.08 vs. price of R$53.25 (15.6% below fair value)
Industry Position: 40.3% below the Medical Diagnostics & Research median (#62 of 95)
No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
74GF Score
Get the complete analysis for BSP:TMOS34
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:TMOS34 has been successfully added to your 
